NO974371L - Epitelialadhesive lactobacilli - Google Patents
Epitelialadhesive lactobacilliInfo
- Publication number
- NO974371L NO974371L NO974371A NO974371A NO974371L NO 974371 L NO974371 L NO 974371L NO 974371 A NO974371 A NO 974371A NO 974371 A NO974371 A NO 974371A NO 974371 L NO974371 L NO 974371L
- Authority
- NO
- Norway
- Prior art keywords
- mannose
- plantarum
- specific
- lactobacilli
- pharmaceutical composition
- Prior art date
Links
- 241000186660 Lactobacillus Species 0.000 title 1
- 239000000853 adhesive Substances 0.000 title 1
- 230000001070 adhesive effect Effects 0.000 title 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 4
- 240000006024 Lactobacillus plantarum Species 0.000 abstract 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 abstract 2
- 244000052616 bacterial pathogen Species 0.000 abstract 2
- 229940072205 lactobacillus plantarum Drugs 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 229920000936 Agarose Polymers 0.000 abstract 1
- 206010070545 Bacterial translocation Diseases 0.000 abstract 1
- 201000001579 bacterial gastritis Diseases 0.000 abstract 1
- 230000007375 bacterial translocation Effects 0.000 abstract 1
- 239000011324 bead Substances 0.000 abstract 1
- 238000009109 curative therapy Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9501056A SE9501056D0 (sv) | 1995-03-23 | 1995-03-23 | Epithelial adherent lactobacilli |
| PCT/SE1996/000372 WO1996029083A1 (en) | 1995-03-23 | 1996-03-25 | Epithelial adhesive lactobacilli |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO974371D0 NO974371D0 (no) | 1997-09-22 |
| NO974371L true NO974371L (no) | 1997-11-20 |
Family
ID=20397666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO974371A NO974371L (no) | 1995-03-23 | 1997-09-22 | Epitelialadhesive lactobacilli |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6159465A (https=) |
| EP (1) | EP0817640B1 (https=) |
| JP (1) | JP4072646B2 (https=) |
| KR (1) | KR100446482B1 (https=) |
| CN (1) | CN1138551C (https=) |
| AT (1) | ATE240738T1 (https=) |
| AU (1) | AU702705B2 (https=) |
| BR (1) | BR9607538A (https=) |
| CA (1) | CA2216150C (https=) |
| DE (1) | DE69628288T2 (https=) |
| EE (1) | EE04097B1 (https=) |
| ES (1) | ES2200057T3 (https=) |
| NO (1) | NO974371L (https=) |
| PL (1) | PL184037B1 (https=) |
| SE (1) | SE9501056D0 (https=) |
| WO (1) | WO1996029083A1 (https=) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100376954B1 (ko) * | 1995-07-31 | 2003-07-18 | 프로비 에이비 | 장에서집락화하는유산간균 |
| JP2002507997A (ja) * | 1997-07-05 | 2002-03-12 | ソシエテ デ プロデユイ ネツスル ソシエテ アノニム | 腸管細胞によるミネラルの吸収 |
| FI974643L (fi) * | 1997-12-30 | 1999-07-01 | Atria Oyj | Biologinen menetelmä salmonellan eliminoimiseksi prosesseista ja rakenteista |
| US6830750B1 (en) * | 1998-10-01 | 2004-12-14 | Probi Ab | Reduction of oxidative stress factors with Lactobacillus plantarum |
| CA2378620A1 (en) * | 1999-08-09 | 2001-02-15 | Pinaki Panigrahi | Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| AP1563A (en) | 1999-10-26 | 2006-02-02 | Nestle Sa | Lactic acid bacteria for the treatment and /or prophylaxis of giardiasis. |
| GB2369777B (en) * | 2000-10-05 | 2004-10-27 | St Ivel Ltd | Food products with antimicrobial lactic acid bacteria |
| SE0004124D0 (sv) * | 2000-11-10 | 2000-11-10 | Probi Ab | New use |
| CA2450444A1 (fr) * | 2001-06-14 | 2002-12-27 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes |
| FR2831555A1 (fr) * | 2001-10-29 | 2003-05-02 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
| FR2826020B1 (fr) * | 2001-06-14 | 2005-02-11 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
| SE527555C2 (sv) * | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
| WO2005086870A2 (en) * | 2004-03-10 | 2005-09-22 | The Board Of Trustees Of The University Of Illinois | Novel lactobacillus strains and method of use |
| EP1730179B1 (en) * | 2004-03-23 | 2010-04-28 | Friesland Brands B.V. | Novel mannose-specific adhesins and their use |
| SE528382C2 (sv) * | 2004-10-05 | 2006-10-31 | Probi Ab | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa |
| JP2006180836A (ja) * | 2004-12-28 | 2006-07-13 | Marudai Food Co Ltd | 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物 |
| JP2006257077A (ja) * | 2005-02-18 | 2006-09-28 | Marudai Food Co Ltd | 免疫調節剤および免疫調節食品 |
| CN1888051B (zh) * | 2005-06-28 | 2010-05-05 | 北京天佑达生物工程科技有限公司 | 一株植物乳杆菌及其应用 |
| SE529199C2 (sv) * | 2005-07-05 | 2007-05-29 | Probi Ab | Förstärkt absorption |
| EP1931363B1 (en) | 2005-09-28 | 2015-11-18 | Nordisk Rebalance A/S | Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors |
| KR101397386B1 (ko) | 2005-12-13 | 2014-05-26 | 엑스테라 메디컬 코퍼레이션 | 혈액으로부터 병원성 미생물, 염증 세포 또는 염증단백질의 체외 제거를 위한 방법 |
| PL210465B1 (pl) | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Zastosowanie kompozycji szczepów z rodzaju Lactobacillus |
| FR2928935B1 (fr) | 2008-03-19 | 2011-05-20 | Gervais Danone Sa | Souche de lactobacillus rhamnosus. |
| EP2459203B1 (en) | 2009-07-30 | 2018-10-31 | DuPont Nutrition Biosciences ApS | Lactic acid bacteria and bifidobacteria for treating endotoxemia |
| ES2861359T3 (es) | 2009-12-01 | 2021-10-06 | Exthera Medical Corp | Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie |
| CN102905712B (zh) | 2010-01-28 | 2015-12-16 | Ab－生物学有限公司 | 用于治疗肠炎的益生菌组合物 |
| WO2012112724A1 (en) | 2011-02-15 | 2012-08-23 | Exthera Medical, Llc | Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines |
| BG66608B1 (bg) * | 2011-05-04 | 2017-10-16 | "Ел Би Булгарикум" ЕАД | Полибактериален пробиотичен препарат |
| CN102618456B (zh) * | 2012-02-28 | 2013-08-21 | 江南大学 | 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途 |
| EP2861273B1 (en) | 2012-06-13 | 2017-08-23 | ExThera Medical Corporation | Use of heparin and carbohydrates to treat cancer |
| JP2012184261A (ja) * | 2012-06-21 | 2012-09-27 | Snow Brand Milk Products Co Ltd | 免疫増強剤 |
| CN102827796B (zh) * | 2012-09-03 | 2013-10-30 | 江南大学 | 一种具有排镉功能的植物乳杆菌及其用途 |
| EP2897638A1 (en) | 2012-09-24 | 2015-07-29 | Montana State University-Bozeman | Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use |
| BR112015032134B1 (pt) | 2013-06-24 | 2022-05-10 | Exthera Medical Corporation | Método de ligação em ponto de extremidade de uma manose não redutora a um substrato e esfera possuindo uma manose ligada em ponto de extremidade |
| BR112016009827B1 (pt) | 2013-11-08 | 2021-10-26 | Exthera Medical Corporation | Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit |
| EP3134146B1 (en) | 2014-04-24 | 2024-12-25 | ExThera Medical Corporation | Method for removing bacteria from blood using high flow rate |
| US10857283B2 (en) | 2014-09-22 | 2020-12-08 | Exthera Medical Corporation | Wearable hemoperfusion device |
| CN108235682A (zh) | 2015-09-29 | 2018-06-29 | 金伯利-克拉克环球有限公司 | 用于维护微生物群落的健康平衡的协同组合物 |
| WO2017151797A1 (en) | 2016-03-02 | 2017-09-08 | Exthera Medical Corporation | Method for treating drug intoxication |
| US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
| KR102769558B1 (ko) | 2017-02-28 | 2025-02-19 | 킴벌리-클라크 월드와이드, 인크. | 미생물총의 건강한 균형을 유지하기 위한 상승적 조성물 |
| KR102024883B1 (ko) | 2017-11-24 | 2019-09-24 | 주식회사 고바이오랩 | 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도 |
| MY202164A (en) | 2018-05-09 | 2024-04-09 | Kobiolabs Inc | Lactobacillus paracasei strain and use thereof |
| KR102138834B1 (ko) | 2018-05-23 | 2020-07-29 | 주식회사 고바이오랩 | 락토바실러스 가세리 kbl697 균주 및 그 용도 |
| WO2020231830A1 (en) | 2019-05-16 | 2020-11-19 | Exthera Medical Corporation | Method for modulating endothelial glycocalyx structure |
| MY199150A (en) | 2019-06-05 | 2023-10-18 | Morinaga Milk Industry Co Ltd | Nutritional composition |
| CN111575223B (zh) * | 2020-05-20 | 2022-04-15 | 江南大学 | 一种降低鼠李糖乳杆菌表面物质分泌量的方法 |
| CN119242500A (zh) * | 2024-09-30 | 2025-01-03 | 尚品健康科技(青岛)有限公司 | 一株母乳来源植物乳植杆菌改善过敏性疾病和调节肠道菌群的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0203586A3 (en) * | 1985-05-29 | 1988-03-09 | Pioneer Hi-Bred International | A composition for treating gastrointestinal disease in animals |
| SE469875C (sv) * | 1991-07-25 | 1997-04-14 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
| GB9124249D0 (en) * | 1991-11-14 | 1992-01-08 | Goldstein Fredric | Ribbon curling and shredding device |
| GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
-
1995
- 1995-03-23 SE SE9501056A patent/SE9501056D0/xx unknown
-
1996
- 1996-03-25 US US08/913,618 patent/US6159465A/en not_active Expired - Lifetime
- 1996-03-25 CN CNB961940867A patent/CN1138551C/zh not_active Expired - Lifetime
- 1996-03-25 AU AU51665/96A patent/AU702705B2/en not_active Expired
- 1996-03-25 PL PL96322550A patent/PL184037B1/pl unknown
- 1996-03-25 KR KR1019970706504A patent/KR100446482B1/ko not_active Expired - Lifetime
- 1996-03-25 AT AT96908428T patent/ATE240738T1/de active
- 1996-03-25 ES ES96908428T patent/ES2200057T3/es not_active Expired - Lifetime
- 1996-03-25 WO PCT/SE1996/000372 patent/WO1996029083A1/en not_active Ceased
- 1996-03-25 EE EE9700329A patent/EE04097B1/xx unknown
- 1996-03-25 JP JP52834796A patent/JP4072646B2/ja not_active Expired - Lifetime
- 1996-03-25 DE DE69628288T patent/DE69628288T2/de not_active Expired - Lifetime
- 1996-03-25 BR BR9607538A patent/BR9607538A/pt not_active Application Discontinuation
- 1996-03-25 EP EP96908428A patent/EP0817640B1/en not_active Expired - Lifetime
- 1996-03-25 CA CA002216150A patent/CA2216150C/en not_active Expired - Lifetime
-
1997
- 1997-09-22 NO NO974371A patent/NO974371L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE9501056D0 (sv) | 1995-03-23 |
| CA2216150A1 (en) | 1996-09-26 |
| BR9607538A (pt) | 1998-01-06 |
| EE04097B1 (et) | 2003-08-15 |
| WO1996029083A1 (en) | 1996-09-26 |
| PL322550A1 (en) | 1998-02-02 |
| ATE240738T1 (de) | 2003-06-15 |
| EE9700329A (et) | 1998-06-15 |
| CA2216150C (en) | 2008-01-22 |
| NO974371D0 (no) | 1997-09-22 |
| EP0817640B1 (en) | 2003-05-21 |
| PL184037B1 (pl) | 2002-08-30 |
| CN1185111A (zh) | 1998-06-17 |
| KR100446482B1 (ko) | 2006-01-27 |
| CN1138551C (zh) | 2004-02-18 |
| EP0817640A1 (en) | 1998-01-14 |
| AU702705B2 (en) | 1999-03-04 |
| AU5166596A (en) | 1996-10-08 |
| ES2200057T3 (es) | 2004-03-01 |
| DE69628288T2 (de) | 2004-04-08 |
| DE69628288D1 (de) | 2003-06-26 |
| JPH11502703A (ja) | 1999-03-09 |
| HK1017989A1 (en) | 1999-12-10 |
| KR19980703102A (ko) | 1998-10-15 |
| JP4072646B2 (ja) | 2008-04-09 |
| US6159465A (en) | 2000-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO974371L (no) | Epitelialadhesive lactobacilli | |
| Jensen et al. | In vitro testing of commercial and potential probiotic lactic acid bacteria | |
| Mu et al. | Probiotic yeast BR14 ameliorates DSS-induced colitis by restoring the gut barrier and adjusting the intestinal microbiota | |
| Esteban‐Fernández et al. | In vitro beneficial effects of Streptococcus dentisani as potential oral probiotic for periodontal diseases | |
| Ocaña et al. | Vaginal lactobacilli: self-and co-aggregating ability | |
| Rios-Covian et al. | Bacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria | |
| HUP9901619A1 (hu) | Streptococcus thermophilus és bifidobacterium longum baktériumokat tartalmazó enterális diétás kompozíciók és azok alkalmazása | |
| WO2020074547A8 (en) | Lactobacillus crispatus probiotic strains suitable for treating urogenital yeast and bacterial infections | |
| NO306699B1 (no) | Tarmkanal-koloniserende lactobasiller, samt fremgangsmåte for isolering og anvendelse derav, samt blanding | |
| Nallala et al. | Molecular characterization of antimicrobial Lactobacillus isolates and evaluation of their probiotic characteristics in vitro for use in poultry | |
| MXPA04000808A (es) | Cepas probioticas de lactobacillus salivarius. | |
| TR200101699T2 (tr) | Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması | |
| CA3027458A1 (en) | Dermatological preparations for maintaining and/or restoring healthy skin microbiota | |
| VidyaLaxme et al. | Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against V. cholerae and other beneficial properties | |
| Sánchez et al. | Identification of novel proteins secreted by Lactobacillus rhamnosus GG grown in de Mann‐Rogosa‐Sharpe broth | |
| Michel et al. | Isolation of an Acanthamoeba strain with intracellular Burkholderia pickettii infection | |
| Tzvetkova et al. | Hydrolysis of major dairy proteins by lactic acid bacteria from Bulgarian yogurts | |
| Melgar-Lalanne et al. | In vitro evaluation of the probiotic potential of halotolerant lactobacilli isolated from a ripened tropical Mexican cheese | |
| EP2464361A2 (de) | Zusammensetzung mit stämmen von lactobazillus fermentum | |
| WO2023281415A3 (en) | Bacteria strains for topical skin care | |
| Sun et al. | Lactobacillus isolates from healthy volunteers exert immunomodulatory effects on activated peripheral blood mononuclear cells | |
| Zhu et al. | Protective effect of Bifidobacterium animalis CGMCC25262 on HaCaT keratinocytes | |
| US5468479A (en) | Compositions containing lactic acid bacterium Streptococcus salivarius | |
| Sophatha et al. | Factors relating to adhesion and aggregation of Lactobacillus paracasei and Lactobacillus rhamnosus strains | |
| Sim et al. | In vitro assessment of the gastrointestinal tolerance and immunomodulatory function of Bacillus methylotrophicus isolated from a traditional Korean fermented soybean food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |